Universitat Internacional de Catalunya
uic.esTotal trials
147
Active
35
Phase 3
1
Total enrollment
11,553
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Penicillin | — | — | — | — | — | 1 | |
| Carbamide peroxide 10% | — | — | — | — | — | 1 |
Next readouts
- 2024-12-31
- 2026-05
Top conditions
- Peri-Implantitis12
- Peri-implant Mucositis8
- Dental Implant5
- Gingival Recession4
- Stroke4
- Peri-implantitis3
- Neuromuscular Diseases3
- Stroke Sequelae3
Frequently asked questions about Universitat Internacional de Catalunya
- How many clinical trials does Universitat Internacional de Catalunya have on ClinicalTrials.gov?
- Universitat Internacional de Catalunya is listed as the lead sponsor on 147 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Universitat Internacional de Catalunya's trials are in Phase 3?
- 1 of Universitat Internacional de Catalunya's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Universitat Internacional de Catalunya focus on?
- Universitat Internacional de Catalunya's most-studied conditions on ClinicalTrials.gov are Peri-Implantitis, Peri-implant Mucositis, Dental Implant, Gingival Recession, Stroke.
- When are Universitat Internacional de Catalunya's next clinical trial readouts?
- Universitat Internacional de Catalunya has 2 upcoming primary-completion readouts tracked here; the soonest is “Do Penicillin-allergic Patients Presents a High Risk of Sinus Lift Failure”, expected around 2024-12-31.